Zobrazeno 1 - 10
of 117
pro vyhledávání: '"Tom T. Shimabukuro"'
Autor:
Elaine R. Miller, Paige Lewis, Tom T. Shimabukuro, John Su, Pedro Moro, Emily Jane Woo, Christopher Jankosky, Maria Cano
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 14, Iss 8, Pp 1963-1969 (2018)
Background: Herpes zoster (HZ), or shingles, is caused by reactivation of varicella-zoster virus in latently infected individuals. Live-attenuated HZ vaccine (zoster vaccine live, ZVL) is approved in the United States for persons aged ≥50 years and
Externí odkaz:
https://doaj.org/article/a245ce01b8d94c07ab83b87e79560d05
Autor:
Tom T. Shimabukuro, Stephen C. Redd
Publikováno v:
Emerging Infectious Diseases, Vol 20, Iss 4, Pp 713-714 (2014)
Externí odkaz:
https://doaj.org/article/ecea61f5cf9b4626a6055b35905441e4
Autor:
Tanya R. Myers, Paige L. Marquez, Julianne M. Gee, Anne M. Hause, Lakshmi Panagiotakopoulos, Bicheng Zhang, Isaac McCullum, Charles Licata, Christine K. Olson, Shakeeb Rahman, Sharon B. Kennedy, Matthew Cardozo, Chirayu R. Patel, Liza Maxwell, Joel R. Kallman, David K. Shay, Tom T. Shimabukuro
Publikováno v:
Vaccine. 41:1310-1318
Autor:
Anne M. Hause, Paige Marquez, Bicheng Zhang, John R. Su, Tanya R. Myers, Julianne Gee, Sarada S. Panchanathan, Deborah Thompson, Tom T. Shimabukuro, David K. Shay
Publikováno v:
MMWR. Morbidity and Mortality Weekly Report. 72:39-43
Autor:
Anne M, Hause, Paige, Marquez, Bicheng, Zhang, Tanya R, Myers, Julianne, Gee, John R, Su, Casey, Parker, Deborah, Thompson, Sarada S, Panchanathan, Tom T, Shimabukuro, David K, Shay
Publikováno v:
MMWR. Morbidity and Mortality Weekly Report. 71:1115-1120
Autor:
Anne M, Hause, James, Baggs, Paige, Marquez, Tanya R, Myers, John R, Su, Brandon, Hugueley, Deborah, Thompson, Julianne, Gee, Tom T, Shimabukuro, David K, Shay
Publikováno v:
MMWR. Morbidity and Mortality Weekly Report. 71:1047-1051
On May 17, 2022, the Food and Drug Administration (FDA) amended the Emergency Use Authorization (EUA) for BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine to authorize a homologous* booster dose for children aged 5-11 years ≥5 months after receipt of th
Autor:
Kristin Goddard, Edwin Lewis, Bruce Fireman, Eric Weintraub, Tom T. Shimabukuro, Ousseny Zerbo, Thomas G. Boyce, Matthew E. Oster, Kayla E. Hanson, James G. Donahue, Pat Ross, Allison L. Naleway, Jennifer C. Nelson, Bruno Lewin, Jason M. Glanz, Joshua T.B. Williams, Elyse O. Kharbanda, W. Katherine Yih, Nicola P. Klein
Publikováno v:
Vaccine. 40:5153-5159
Evidence indicates that mRNA COVID-19 vaccination is associated with risk of myocarditis and possibly pericarditis, especially in young males. It is not clear if risk differs between mRNA-1273 versus BNT162b2. We assessed if risk differs using compre
Autor:
Elaine R. Miller, Pedro L. Moro, Tom T. Shimabukuro, Grace Carlock, Shaeyla N. Davis, Emma M. Freeborn, Amy L. Roberts, Julianne Gee, Allan W. Taylor, Ruth Gallego, Tiffany Suragh, John R. Su
Publikováno v:
Vaccine.
Autor:
Anne M. Hause, James Baggs, Paige Marquez, Winston E. Abara, Babatunde Olubajo, Tanya R. Myers, John R. Su, Deborah Thompson, Julianne Gee, Tom T. Shimabukuro, David K. Shay
Publikováno v:
MMWR. Morbidity and Mortality Weekly Report. 71:347-351
Autor:
Anne M, Hause, James, Baggs, Paige, Marquez, Tanya R, Myers, John R, Su, Phillip G, Blanc, Jane A, Gwira Baumblatt, Emily Jane, Woo, Julianne, Gee, Tom T, Shimabukuro, David K, Shay
Publikováno v:
MMWR. Morbidity and Mortality Weekly Report. 71:249-254
During September 22, 2021-February 6, 2022, approximately 82.6 million U.S. residents aged ≥18 years received a COVID-19 vaccine booster dose.* The Food and Drug Administration (FDA) has authorized a booster dose of either the same product administ